A new method for discovering antibiotics makes use of an unusual source of complex microbial communities: bear saliva.
A promising candidate is on the verge of entering clinical development… What happens when you see an opportunity to make it even better?
Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.
With big pharma seemingly pulling out of the field, what hope remains for novel treatments for Alzheimer’s disease?
Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?
Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.
Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.
New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.
What characteristics make a cancer therapy more likely to effectively treat disease?
Digital technologies could transform healthcare.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.